P. Schraml et al., Allelic loss at the D9S171 focus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma, J PATHOLOGY, 190(4), 2000, pp. 457-461
Citations number
40
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Papillary renal cell carcinomas (RCCs) have characteristic clinical and mor
phological features that separate them from the more common clear cell RCCs
, The details of the molecular changes in papillary RCC progression are not
well understood. In this study, four highly polymorphic microsatellite mar
kers [D9S970 (9p12-9p13), D9S171 (9p13), D9S1748 (9p21) and D9S156 (9p21)]
were used to determine the frequency and prognostic significance of 9p dele
tions in 37 papillary RCCs, Allelic deletions were detected in eight cases
(22%), The highest rate of loss of heterozygosity (LOH) was observed in 6 o
f 29 informative patients (21%) at the D9S171 locus on 9p13, Only two patie
nts displayed allelic loss at D9S1748, which resides in close proximity to
p16(INK4). TWO Of 24 informative papillary RCCs (8%) showed LOH for D9S970,
LOH at D9S171 (9p13) was associated with short patient survival (p = 0.008
), independently of tumour grade and stage, These data suggest a tumour sup
pressor gene centromeric to 9p21 that may contribute to papillary RCC progr
ession. Copyright (C) 2000 John Wiley & Sons, Ltd.